Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
From CNBC.com News
 
   Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
   
  
  February 20, 2024
  From CNBC.com News
 
   AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
   
  
  February 20, 2024
  From CNBC.com News
 
   Elon Musk says first Neuralink patient can control a computer mouse through thinking
   
  
  February 20, 2024
  From CNBC.com News
 
   Biden administration examining role of supply chain middlemen in generic drug shortages
   
  
  February 14, 2024
  From CNBC.com News
 
   Healthy Returns: Higher medical costs are pinching insurers
   
  
  February 13, 2024
  From CNBC.com News
 
   Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
   
  
  February 13, 2024
  From CNBC.com News
 
   Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
   
  
  February 13, 2024
  From CNBC.com News
 
   Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
   
  
  February 10, 2024
  From CNBC.com News
 
   Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
   
  
  February 08, 2024
  From CNBC.com News
 
   Enphase CEO says solar industry poised to rebound on falling interest rates and rising utility costs
   
  
  February 07, 2024
  From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes
   
  
  February 06, 2024
  From CNBC.com News
 
   Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
   
  
  February 06, 2024
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.